Alkosign

Why is Alkosign Ltd falling/rising?

As of 24-Jun, Alkosign Ltd's stock price is rising by 0.93%, despite a year-to-date decline of 24.52%. The increase may reflect broader market trends and heightened investor interest, but the stock remains below its moving averages, indicating an overall negative trend.

As of 24-Jun, Alkosign Ltd's stock price is currently rising, with a change of 0.5, representing an increase of 0.93%. This rise occurs despite the stock's overall performance being negative over various periods, including a year-to-date decline of 24.52% and a one-year drop of 21.84%. <BR><BR>The stock's performance today is reported to be in line with the sector, indicating that the increase may be part of a broader market trend rather than isolated to Alkosign Ltd. Additionally, there has been a notable rise in investor participation, with delivery volume on June 19 increasing by 25% compared to the five-day average, suggesting growing interest in the stock. <BR><BR>However, it is important to note that Alkosign is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bearish trend. The stock has also experienced erratic trading, having not traded on two days out of the last 20. <BR><BR>In summary, while the stock is currently experiencing a rise in price, the overall trend remains negative, and the increase may be influenced by increased trading activity rather than a fundamental improvement in the company's performance.

Which are the latest news on Alkosign?

What does Alkosign do?

Alkosign Ltd, a micro-cap company incorporated in 2020, reported net sales of 11 Cr and a net profit of 1 Cr for December 2024. It has a market cap of INR 66 Cr, a P/E ratio of 7.00, and a debt-to-equity ratio of 0.40.

Overview:<BR>Alkosign Ltd operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Alkosign Limited was incorporated in the year 2020 as a Private Limited Company under the name "Alkosign Private Limited." The Certificate of Incorporation was issued on March 20, 2020, by the Assistant Registrar of Companies, Mumbai. The latest quarterly results reported are for December 2024, showing net sales and profit.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 11 Cr (Quarterly Results - Dec 2024)<BR>Most recent Net Profit: 1 Cr (Quarterly Results - Dec 2024)<BR>Market-cap value: INR 66 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 7.00<BR>Industry P/E: 53<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.40<BR>Return on Equity: 0.31%<BR>Price to Book: 1.82<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Alkosign?

As of 10th June, Alkosign Ltd has a market capitalization of 66.00 Cr, with recent net sales of 11.19 Cr and a net profit of 0.94 Cr for the quarter ending December 2024. The balance sheet for March 2025 shows shareholder's funds of 32.99 Cr and total assets of 50.92 Cr.

As of 10th June, Alkosign Ltd has a market capitalization of 66.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest quarter ending December 2024, Alkosign reported Net Sales of 11.19 Cr and a Net Profit of 0.94 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 32.99 Cr and Total Assets of 50.92 Cr.

Who are in the management team of Alkosign?

The management team of Alkosign includes Chairman Samir Narendra Shah, Whole-Time Director Akshay Narendra Shah, and several Non-Executive and Independent Non-Executive Directors, providing a blend of executive leadership and independent oversight.

The management team of Alkosign includes the following individuals:<BR><BR>1. **Samir Narendra Shah** - Chairman / Executive Director<BR>2. **Akshay Narendra Shah** - Whole-Time Director & Executive Director<BR>3. **Shrenik Kamlesh Shah** - Non-Executive Director<BR>4. **Zeenal Shrenik Shah** - Non-Executive Director<BR>5. **Parshva Vinaykant Doshi** - Independent Non-Executive Director<BR>6. **Yogesh Ramgopal Gupta** - Independent Non-Executive Director<BR>7. **Seema Ashim Jhaveri** - Independent Non-Executive Director<BR>8. **Priya Navin Kapoor** - Independent Non-Executive Director<BR><BR>This team brings a mix of executive and independent oversight to the company.

Who are the peers of the Alkosign?

Alkosign's peers include Anmol India, Ravi Leela Gran, and Yash Chemex, among others. Alkosign has below-average management risk and a 1-year return of -13.28%, better than Anmol India's -38.66% but worse than Ravi Leela Gran's 34.44%.

Peers: The peers of Alkosign are Anmol India, Ravi Leela Gran, Yash Chemex, Supreme Facility, Mohini Health, Graphisads, ANI Integrated, Priti Internati., AVSL Industries.<BR><BR>Quality Snapshot: Good management risk is observed at Anmol India and AVSL Industries, while Average management risk is found at Supreme Facility and Priti Internati. Below Average management risk is noted for Alkosign, Ravi Leela Gran, Yash Chemex, Mohini Health, Graphisads, and ANI Integrated. Growth is Excellent at Pulz Electronics, Good at Ravi Leela Gran, and Below Average at Alkosign, Anmol India, Yash Chemex, Supreme Facility, Mohini Health, Graphisads, ANI Integrated, Priti Internati., and AVSL Industries. Capital Structure is Good at Priti Internati., Average at Anmol India, ANI Integrated, and AVSL Industries, and Below Average at Alkosign, Ravi Leela Gran, Yash Chemex, Supreme Facility, Mohini Health, and Graphisads.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Ravi Leela Gran at 34.44%, while the peer with the lowest is Anmol India at -38.66%. Alkosign's 1-year return is -13.28%, which is better than Anmol India but worse than Ravi Leela Gran. Additionally, several peers, including Yash Chemex, Anmol India, and AVSL Industries, have negative six-month returns.

When is the next results date for Alkosign Ltd?

The next results date for Alkosign Ltd is 29 May 2026.

The next results date for Alkosign Ltd is scheduled for 29 May 2026.

Is Alkosign overvalued or undervalued?

As of November 28, 2025, Alkosign's valuation has shifted to fair with a PE ratio of 21.33, lower than peers like Century Plyboard and Greenply Industries, indicating it is fairly valued despite a recent 4.52% stock return compared to the Sensex's 8.43%.

As of 28 November 2025, Alkosign's valuation grade has moved from attractive to fair, indicating a shift in its market perception. The company is currently fairly valued, with a PE ratio of 21.33, an EV to EBITDA of 12.00, and a PEG ratio of 0.05, suggesting that while growth prospects may be favorable, the current price does not reflect significant undervaluation.<BR><BR>In comparison to its peers, Alkosign's PE ratio is notably lower than that of Century Plyboard, which stands at 76.51, and Greenply Industries, which has a PE of 43.4. This places Alkosign in a more favorable light relative to its peers, particularly when considering its solid ROCE of 11.55% and ROE of 11.29%. Despite recent stock performance showing a 4.52% return over the past year compared to the Sensex's 8.43%, the valuation metrics indicate that Alkosign is fairly positioned in the market.

How has been the historical performance of Alkosign?

Alkosign experienced significant growth from March 2024 to March 2025, with net sales rising to 51.53 Cr, operating profit increasing to 8.13 Cr, and profit after tax reaching 3.77 Cr. The company's financial health improved, evidenced by a decrease in total debt and an increase in shareholder's funds to 32.99 Cr.

Answer:<BR>The historical performance of Alkosign shows significant growth in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Alkosign's net sales increased from 35.69 Cr in March 2024 to 51.53 Cr in March 2025, reflecting a strong growth trajectory. Total operating income followed suit, rising to 51.53 Cr from 35.69 Cr, while total expenditure also increased to 43.72 Cr from 31.19 Cr. The operating profit (PBDIT) excluding other income improved to 7.81 Cr from 4.50 Cr, leading to an overall operating profit of 8.13 Cr, up from 4.78 Cr. Profit before tax surged to 4.62 Cr from 0.67 Cr, and profit after tax rose significantly to 3.77 Cr from 0.78 Cr. The earnings per share (EPS) also saw a notable increase, reaching 3.49 from 1.08. On the balance sheet, shareholder's funds grew to 32.99 Cr from 29.22 Cr, while total liabilities increased slightly to 50.92 Cr from 49.70 Cr. The total debt decreased to 12.55 Cr from 13.84 Cr, indicating improved financial health. Cash flow from operating activities remained at 0.00 Cr, but net cash inflow improved to 5.00 Cr from a previous outflow. Overall, Alkosign demonstrated robust growth in sales, profits, and shareholder equity, positioning itself favorably in the market.

Who are the top shareholders of the Alkosign?

The top shareholders of Alkosign include Naina Narendra Shah with 15.02%, Aegis Investment Fund Pcc at 9.94%, and foreign institutional investors also holding 9.94%. Individual investors collectively own 37.74%, with no pledged promoter holdings or mutual fund shares.

The top shareholders of Alkosign are as follows:<BR><BR>1. Naina Narendra Shah, who is the promoter with the highest holding, owns 15.02% of the company.<BR>2. Aegis Investment Fund Pcc is the highest public shareholder, holding 9.94%.<BR>3. Additionally, foreign institutional investors (FIIs) hold 9.94% through one FII.<BR>4. Individual investors collectively own 37.74% of the company.<BR><BR>There are no pledged promoter holdings, and mutual funds do not hold any shares in Alkosign.

What is the technical trend for Alkosign?

As of June 5, 2025, Alkosign's technical trend has shifted to sideways, with mixed signals from various indicators, including mildly bullish weekly MACD and bearish monthly MACD, resulting in a neutral stance overall.

As of 5 June 2025, the technical trend for Alkosign has changed from mildly bearish to sideways. The current stance is neutral with a mixed strength. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting signals. The weekly RSI shows no signal, but the monthly RSI is bullish. Bollinger Bands are bullish on the weekly chart but mildly bearish on the monthly. Daily moving averages are mildly bearish, and the weekly KST is bearish. Dow Theory supports a mildly bullish stance on both weekly and monthly time frames. Overall, the indicators present a mixed picture, leading to a sideways trend.

Has Alkosign declared dividend?

No Dividend History Available